UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044769
Receipt number R000051138
Scientific Title Autonomic nervous system in dry eye
Date of disclosure of the study information 2021/09/01
Last modified on 2023/08/08 12:39:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pathology in short BUT dry eye

Acronym

Pathology in short BUT dry eye

Scientific Title

Autonomic nervous system in dry eye

Scientific Title:Acronym

Autonomic nervous system in dry eye

Region

Japan


Condition

Condition

dry eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the characteristics of short BUT dry eye in tear fluid and autonomic nervous activity and examine its association with dry eye symptoms

Basic objectives2

Others

Basic objectives -Others

observation of autonomic nervous activity

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

autonomic activity

Key secondary outcomes

dry eye examinations, Idra, OSDI, stress questionnaire, mucin in tears


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Volunteers who understand the research and agree to the research cooperation except for the excluded criteria

Key exclusion criteria

People with diabetes, heart disease, glaucoma instillation, contact lens users

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Minako
Middle name
Last name Kaido

Organization

Wada eye clinic

Division name

ophthalmology

Zip code

2940045

Address

Houjyo2578-27, Tateyama-shi, Chiba

TEL

0470226311

Email

tomoulton777@ff.em-net.ne.jp


Public contact

Name of contact person

1st name Minako
Middle name
Last name Kaido

Organization

Wada eye clinic

Division name

ophthalmology

Zip code

2940045

Address

Houjyo2578-27, Tateyama-shi, Chiba

TEL

0470226311

Homepage URL


Email

tomoulton777@ff.em-net.ne.jp


Sponsor or person

Institute

Wada eye clinic

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ito Clinic

Address

Ooazaminaminakano626-11,Minuma-ku, Saitama City, Saitama

Tel

048-686-5588

Email

arita.reiko@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 01 Day

Date of IRB

2021 Year 03 Month 27 Day

Anticipated trial start date

2021 Year 07 Month 10 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry

2021 Year 10 Month 31 Day

Date trial data considered complete

2021 Year 10 Month 31 Day

Date analysis concluded

2021 Year 11 Month 15 Day


Other

Other related information

(1)Tear function test, (2) Idra, (3) OSDI dry eye questionnaire and stress check questionnaire, (4) measurement of mucin level in tears, (5) evaluation of autonomic nerve activity (Silmee; TDK) are performed, and dry eye and non-dry eye are compared.


Management information

Registered date

2021 Year 07 Month 06 Day

Last modified on

2023 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051138